Covington advised Bristol Myers Squibb on the transaction, while Cooley and Wilson Sonsini Goodrich & Rosati advised RayzeBio Inc. Goodwin advised Centerview Partners in its role...
Bristol Myers Squibb’s $4.1 Billion Acquisition of RayzeBio
OrbiMed’s $125 Million Debt Financing
Covington & Burling advised OrbiMed on the deal. OrbiMed announced its $125 million debt financing with Verrica Pharmaceuticals, a dermatology therapeutics company developing medications for skin diseases...
Prudential Financial’s $10 Billion Block Reinsurance Transaction
Willkie advised Prudential Financial, Inc. on the deal. Prudential Financial, Inc. closed its agreement to reinsure a $10 billion portion of its traditional variable annuity block...
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
Insmed Incorporated’s $775 Million Financing
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
Talcott Resolution’s $25 Billion Reinsurance Transaction with Principal Financial Group
Willkie Farr & Gallagher represented Sixth Street in the transaction between an affiliate of Talcott Resolution and Principal. Sixth Street announced that a non-U.S. affiliate of...
Resolution Life’s Reinsurance Agreement With Allianz Life
Debevoise & Plimpton advised Resolution Life in the deal, while Willkie represented Sixth Street. Resolution Life announced the reinsurance of $35 billion in fixed indexed annuities...
Human Interest’s $200 Million Series D Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Human Interest on the deal, while Ropes & Gray advised The Rise Fund. Human Interest has raised a...